CKD: Consolidated financial results for the first quarter ending March 2025 (based on Japanese standards)
CKD: Announcements of individual stocks regarding the completion of payment for the disposal of treasury stock as share compensation with transfer restrictions to directors.
CKD: (Revised) Notice of the 102nd to 104th Regular Shareholders Meeting
CKD: Regarding the partial correction of the English version of the 'Notice of convocation of the 102nd to 104th ordinary general meetings of shareholders'.
CKD: Interim report
CKD: Report on Corporate Governance as of June 24, 2024.
CKD: Announcements of individual stocks regarding the disposal of self-owned stocks as stock rewards with transfer restrictions for directors.
CKD: Financial Report - 104th Term (2023/04/01 - 2024/03/31)
CKD: Confirmation letter
CKD: Internal Control Report - 104th Fiscal Year (2023/04/01 - 2024/03/31)
CKD: Notice of the 104th Annual General Meeting of Shareholders
CKD: 2024 Annual General Meeting of Shareholders Convocation Notice
CKD: Independent Officer Notification Form
CKD: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
CKD: Notice regarding changes in representative directors and officers
CKD: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
CKD: Notice regarding dividends from surplus funds
CKD: Notice regarding completion of payment of treasury stock disposal as share compensation with transfer restrictions to executive officers, etc.
CKD: Change Report (Stock Certificates Subject to Special Cases, etc.)
CKD: Notice regarding disposal of treasury stock as share compensation with transfer restrictions for executive officers, etc.
No Data